NYSE
TARO

Taro Pharmaceutical Industries Ltd

PHARMACEUTICAL PREPARATIONS
LIFE SCIENCES

Prices are adjusted according to historical splits.

Taro Pharmaceutical Industries Ltd Stock Price

Vitals

Today's Low:
$28.8000
Today's High:
$30.0600
Open Price:
$30.0600
52W Low:
$28.26
52W High:
$58.95
Prev. Close:
$30.0600
Volume:
14233

Company Statistics

Market Cap.:
$1.086 billion
Book Value:
45.4
Revenue TTM:
$0.569 billion
Operating Margin TTM:
11.5%
Gross Profit TTM:
$0.293 billion
Gross Profit TTM:
$0.293 billion
Profit Margin:
11.4%
Return on Assets TTM:
1.85%
Return on Equity TTM:
3.85%

Company Profile

Taro Pharmaceutical Industries Ltd had its IPO on 1993-04-01 under the ticker symbol TARO.

The company operates in the LIFE SCIENCES sector and PHARMACEUTICAL PREPARATIONS industry. Taro Pharmaceutical Industries Ltd has a staff strength of 0 employees.

Stock update

Shares of Taro Pharmaceutical Industries Ltd opened at $30.06 at the start of the last trading session i.e. 2022-11-02.

The stocks traded within a range of $28.8 - $30.06, and closed at $28.9.

This is a -3.86% slip from the previous day's closing price.

A total volume of 14,233 shares were traded at the close of the day’s session.

In the last one week, shares of Taro Pharmaceutical Industries Ltd have slipped by -12.42%.

Taro Pharmaceutical Industries Ltd's Key Ratios

Taro Pharmaceutical Industries Ltd has a market cap of $1.086 billion, indicating a price to book ratio of 0.659 and a price to sales ratio of 1.908.

In the last 12-months Taro Pharmaceutical Industries Ltd’s revenue was $0.569 billion with a gross profit of $0.293 billion and an EBITDA of $0.093 billion. The EBITDA ratio measures Taro Pharmaceutical Industries Ltd's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Taro Pharmaceutical Industries Ltd’s operating margin was 11.5% while its return on assets stood at 1.85% with a return of equity of 3.85%.

In Q3, Taro Pharmaceutical Industries Ltd’s quarterly earnings growth was a negative -18.6% while revenue growth was a negative 1.1%.

Taro Pharmaceutical Industries Ltd’s PE and PEG Ratio

Forward PE
8.69
Trailing PE
11.89
PEG
0

Its diluted EPS in the last 12-months stands at $2.43 per share while it has a forward price to earnings multiple of 8.69 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Taro Pharmaceutical Industries Ltd’s profitability.

Taro Pharmaceutical Industries Ltd stock is trading at a EV to sales ratio of 0.545 and a EV to EBITDA ratio of 3.927. Its price to sales ratio in the trailing 12-months stood at 1.908.

Taro Pharmaceutical Industries Ltd stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$0.000 billion
Total Liabilities
$0.000 billion
Operating Cash Flow
$0.000 billion
Capital Expenditure
$0.000 billion
Dividend Payout Ratio
0%

Taro Pharmaceutical Industries Ltd ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.

Taro Pharmaceutical Industries Ltd ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.

Taro Pharmaceutical Industries Ltd’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.

In 1970, Taro Pharmaceutical Industries Ltd's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.

Comparatively, Taro Pharmaceutical Industries Ltd paid $0 billion in dividends in 1970.

Other key metrics

Current Trading Price
$28.9
52-Week High
$58.95
52-Week Low
$28.26
Analyst Target Price
$54

Taro Pharmaceutical Industries Ltd stock is currently trading at $28.9 per share. It touched a 52-week high of $58.95 and a 52-week low of $58.95. Analysts tracking the stock have a 12-month average target price of $54.

Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.

Frequently Asked Questions About Taro Pharmaceutical Industries Ltd

The stock symbol (also called stock or share ticker) of Taro Pharmaceutical Industries Ltd is TARO

The IPO of Taro Pharmaceutical Industries Ltd took place on 1993-04-01

Similar Industry Stocks (PHARMACEUTICAL PREPARATIONS)

Last Price
Chg
Chg%
$5.03
-0.02
-0.4%
$6.53
-0.37
-5.36%
$8.76
-0.36
-3.95%
$17.63
-0.92
-4.96%
$13.13
-0.15
-1.13%

Most Active

Last Price
Chg
Chg%
$58.63
-1.03
-1.73%
$92.12
-4.67
-4.82%
$5.12
-0.61
-10.65%
Apple Inc (AAPL)
$145.03
-5.62
-3.73%
$0.06
0.01
+12.74%

Top Gainers

Last Price
Chg
Chg%
$73
42.7
+140.92%
$0.02
0.01
+100%
Oi S.A (OIBR-C)
$0
0
+100%
$0.25
0.1
+66.44%
$2.85
1.01
+54.86%

Top Losers

Last Price
Chg
Chg%
$5.36
-22.58
-80.82%
$0.02
-0.06
-78.67%
Air T, Inc (AIRTW)
$0.01
-0.03
-75%
$4.51
-5.17
-53.41%
$11.5
-12.2
-51.48%

About

Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company is headquartered in Haifa Bay, Israel.

Address

14 HAKTOR ST, HAIFA BAY, IL